Schroder Investment Management Group
PBYI icon

Schroder Investment Management Group’s Puma Biotechnology PBYI Stock Holding History

Schroder Investment Management Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-121,876
Closed -$1.27M – 1380
2020
Q2 		$1.27M Buy
+121,876
New +$1.26M ﹤0.01% 883
2018
Q4 		– Sell
-120,640
Closed -$5.53M – 1277
2018
Q3 		$5.53M Buy
120,640
+183
+0.2% +$8.82K 0.01% 686
2018
Q2 		$6.79M Sell
120,457
-224,508
-65% -$13M 0.01% 669
2018
Q1 		$23.5M Buy
344,965
+3,175
+0.9% +$238K 0.04% 426
2017
Q4 		$33.8M Sell
341,790
-4,579
-1% -$512K 0.06% 370
2017
Q3 		$40.6M Sell
346,369
-33,365
-9% -$3.1M 0.07% 324
2017
Q2 		$32.9M Sell
379,734
-424,192
-53% -$23.7M 0.06% 363
2017
Q1 		$30.1M Buy
803,926
+149,205
+23% +$5.44M 0.05% 378
2016
Q4 		$20.1M Buy
+654,721
New +$28.3M 0.04% 484

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Schroder Investment Management Group's PBYI Position: Q3 2020 in Review

Schroder Investment Management Group sold out of Puma Biotechnology (PBYI) in Q3 2020, closing a stake of 121,876 shares — an estimated $1.27M sold.

Schroder Investment Management Group first reported a position in PBYI in Q4 2016 and held it in 9 quarters. The position peaked at $40.6M in Q3 2017. 128 funds tracked by Wall St. Rank hold PBYI as of Q3 2020.

  • Schroder Investment Management Group reported no remaining Puma Biotechnology position as of Q3 2020 after selling out during the quarter.
  • Schroder Investment Management Group sold 121,876 Puma Biotechnology shares in Q3 2020, an estimated $1.27M.
  • Schroder Investment Management Group first reported a position in Puma Biotechnology in Q4 2016 and held it in 9 quarters.
  • Schroder Investment Management Group's Puma Biotechnology position peaked at $40.6M in Q3 2017.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2020.

Based on Schroder Investment Management Group's 13F filing for Q3 2020, filed 13 Nov 2020.